Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Cyclin D1 Antibodies:
anti-Mouse (Murine) Cyclin D1 Antibodies:
anti-Rat (Rattus) Cyclin D1 Antibodies:
Go to our pre-filtered search.
Human Monoclonal Cyclin D1 Primary Antibody for ICC, IHC (fro) - ABIN3043639
Li, Xu, Chu, Gao, Wang, Nie, Yang, Lv: Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE (-/-) mice. in Immunology letters 2013
Show all 23 Pubmed References
Human Polyclonal Cyclin D1 Primary Antibody for WB - ABIN3044355
Ren, Huang, Xu, Yang, Yang, Hu: Isoflavone lupiwighteone induces cytotoxic, apoptotic, and antiangiogenic activities in DU-145 prostate cancer cells. in Anti-cancer drugs 2015
Show all 23 Pubmed References
Human Monoclonal Cyclin D1 Primary Antibody for IHC (p) - ABIN1687223
Kunder, Calzada-Wack, Hölzlwimmer, Müller, Kloss, Howat, Schmidt, Höfler, Warren, Quintanilla-Martinez et al.: A comprehensive antibody panel for immunohistochemical analysis of formalin-fixed, paraffin-embedded hematopoietic neoplasms of mice: analysis of mouse specific and human antibodies cross-reactive ... in Toxicologic pathology 2007
Show all 172 Pubmed References
Human Monoclonal Cyclin D1 Primary Antibody for IHC (p), WB - ABIN1686967
Tsai, Morais, Alshalalfa, Tan, Haddad, Hicks, Gupta, Epstein, Netto, Isaacs, Luo, Mehra, Vessella, Karnes, Schaeffer, Davicioni, De Marzo, Lotan: Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas. in Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Show all 174 Pubmed References
Human Polyclonal Cyclin D1 Primary Antibody for WB - ABIN5518654
Li, Zhu, Liu, Liu, Wang, Xiong, Shen, Hu, Zheng: ZFX knockdown inhibits growth and migration of non-small cell lung carcinoma cell line H1299. in International journal of clinical and experimental pathology 2013
Show all 23 Pubmed References
Goat Polyclonal Cyclin D1 Primary Antibody for FACS, IF (cc) - ABIN671016
Li, Yu, Liu, Zhu, He, Peng, Hua: miR-34c works downstream of p53 leading to dairy goat male germline stem-cell (mGSCs) apoptosis. in Cell proliferation 2013
Show all 15 Pubmed References
Human Polyclonal Cyclin D1 Primary Antibody for WB - ABIN1881175
Aggarwal, Vaites, Kim, Mellert, Gurung, Nakagawa, Herlyn, Hua, Rustgi, McMahon, Diehl: Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. in Cancer cell 2010
Show all 5 Pubmed References
Human Monoclonal Cyclin D1 Primary Antibody for FACS, IP - ABIN967430
Bates, Rowan, Vousden: Characterisation of human cyclin G1 and G2: DNA damage inducible genes. in Oncogene 1996
Show all 5 Pubmed References
Human Monoclonal Cyclin D1 Primary Antibody for IHC (f), IHC (fro) - ABIN967539
Darzynkiewicz, Gong, Juan, Ardelt, Traganos: Cytometry of cyclin proteins. in Cytometry 1997
Show all 4 Pubmed References
Human Polyclonal Cyclin D1 Primary Antibody for IHC (p), WB - ABIN4301538
Ray, Vasudevan, Sengupta: 6-Shogaol Inhibits Breast Cancer Cells and Stem Cell-Like Spheroids by Modulation of Notch Signaling Pathway and Induction of Autophagic Cell Death. in PLoS ONE 2015
Show all 2 Pubmed References
Results suggest that the TCF (show HNF4A Antibodies)/LEF signaling pathway participates in the regulation of cyclin D1 induction during the generation of the dorsal nervous system in early frog embryogenesis.
while cyclin B1 RNA granules were disassembled in a manner dependent on actin filament depolymerization, certain fractions of mos RNA granules were disassembled independently of actin filaments. These results suggest that cytoplasmic regulation of translationally repressed mRNAs by formation of different RNA granules is a key mechanism for translational control of
Maid (show CCNDBP1 Antibodies) is important regulator of hepatocarcinogenesis and aging
show that the knockdown of smc1a (show SMC1A Antibodies) in zebrafish impairs neural development, increases apoptosis, and specifically down-regulates Ccnd1 levels
Reduction of cyclin D1 expression compromises zebrafish eye and head development.
Role in cell cycle control is mediated by meis1 (show MEIS1 Antibodies) regulating cyclin D1 and c-myc (show MYC Antibodies) transcription in the embryonic eye.
results showed that fascaplysin inhibited ovarian cancer cell proliferation, invasion and migration, as well as inducing S arrest and cell apoptosis. Treatment with fascaplysin also suppressed CDK4 (show CDK4 Antibodies), cyclin D1, Bcl-2 (show BCL2 Antibodies), and VEGFA (show VEGFA Antibodies) expression at protein levels
Mutation in the CCND1 gene is associated with acute myeloid leukemia (show BCL11A Antibodies).
The first preclinical study evaluates the response to CDK4/6 (show CDK4 Antibodies) inhibition in endometrial malignancies driven by PTEN (show PTEN Antibodies) deficiency, and it reveals an important role of cyclin D-CDK4/6 (show CDK4 Antibodies) activity in their development.
High CCND1 expression is associated with oropharyngeal squamous cell carcinoma.
Describe a regulatory loop miR (show MLXIP Antibodies)-218-CDK6 (show CDK6 Antibodies)/CyclinD1-E2F1 (show E2F1 Antibodies) whose disruption may contribute to cell cycle progression in gastric cancer.
EGF (show EGF Antibodies) induces hair follicle-derived mesenchymal stem cell proliferation through the EGFR (show EGFR Antibodies)/ERK (show EPHB2 Antibodies) and AKT (show AKT1 Antibodies) pathways, but not through STAT-3 (show STAT3 Antibodies). The G1/S transition was stimulated by upregulation of cyclinD1 and inhibition of p16 (show CDKN2A Antibodies) expression.
Case Report: in the absence of the typical CCND1/IGH@ fusion, t(11;12)(q13;p11.2) promotes Mantle cell lymphoma pathogenesis by eliminating miRNA interaction elements within the 3'-UTR (show UTS2R Antibodies) of the CCND1 mRNA transcript consequently resulting in CCND1 overexpression.
The CCND1 genes were found very close to the IGH locus in naive B cells and further away after maturation. In contrast, the CMYC (show MYC Antibodies) alleles became localized closer to an IGH locus at the stage of SHM (show CNTNAP1 Antibodies)/CSR (show MORF4 Antibodies).
Consistently, samples from oral squamous cell carcinoma (OSCC) patients exhibited a noticeably stronger CREPT (show RPRD1B Antibodies) expression than noncancerous samples. In contrast, knocking down of CREPT (show RPRD1B Antibodies) in OSCC cell lines significantly reduced proliferation, colony formation and migration as well as the expression of cyclin D1 and c-Myc (show MYC Antibodies), but promoted apoptosis.
Histone H2A T120 phosphorylation promotes oncogenic transformation via upregulation of cyclin D1.
NMB or NMBR (show NMBR Antibodies) silencing inhibited M-CSF (show CSF1R Antibodies)/c-Fms (show CSF1R Antibodies)-mediated downstream signaling pathways like activation of ERK (show EPHB2 Antibodies) and Akt (show AKT1 Antibodies) and induction of D-type cyclins, cyclin D1 and D2.
our results are consistent with an epithelial proliferative growth mechanism linking CTNNB1 (show CTNNB1 Antibodies)-driven Ccnd1 transcription and estrogen-mediated CCND1 protein stabilization.
identify Pax5 (show PAX5 Antibodies) and cyclin D1 as Zfp521 (show ZNF521 Antibodies) target genes, and suggest that excessive B-cell proliferation observed in mice with retroviral insertions near the Zfp521 (show ZNF521 Antibodies) gene is due to an up-regulation of cyclin D1 in B-cells.
Data show that expression of the Oct-4 (show POU5F1 Antibodies), Sox2 (show SOX2 Antibodies), Klf4 (show KLF4 Antibodies), and c-Myc (show MYC Antibodies) (OSKM) reprogramming factors induces Cyclin D1 expression, and the increased Cyclin D1 expression during reprogramming promotes continuing embryonic fibroblasts (MEFs) proliferation.
study shows that PLCgamma1 (show PLCG1 Antibodies) controls osteoclast numbers via a CSF-1 (show CSF1 Antibodies)-dependent DAG/beta-catenin (show CTNNB1 Antibodies)/cyclinD1 pathway.
Regarding extratelomeric activities, our results showed a decrease of 64, 38 and 25% in the transcription of c-Myc (show MYC Antibodies), Cyc (show CYCS Antibodies)-D1 and TERT (show TERT Antibodies), respectively (p<0.05) after AZT treatment. Furthermore, we found an effect on cell migration, reaching an inhibition of 48% (p<0.05) and a significant passage-dependent increase on cell doubling time during treatment.
Using Ccnd1 knockout mice, the study shows that Ccnd1 expression significantly contributes to tumor incidence in teratoma (show DND1 Antibodies) susceptible mice without being necessary for normal germ cell or testis development.
Ras (G12V)-induced cyclin D1 protein synthesis was markedly suppressed by the knockdown of IL-33 (show IL33 Antibodies).
Novel RNA-binding activity of MYF5 (show MYF5 Antibodies) enhances Ccnd1 mRNA translation during myogenesis.
cyclin D1, CDK2 (show CDK2 Antibodies) and CDK4 (show CDK4 Antibodies) are expressed in both caruncular and intercaruncular cells derived from both nonpregnant, and artificially inseminated cows on days 30 and 60 of gestation
17beta-estradiol (E2) induces cell proliferation of bovine arterial endothelial cells through upregulation of cyclin D1 via non-genomic activation of the extracellular signal-regulated microtubule-associated Protein 2 kinase (ERK1 (show MAPK3 Antibodies) kinase) pathway.
The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis.
G1/S-specific cyclin-D1 b
, cyclin D1 b
, parathyroid adenomatosis 1
, cyclin D1 (PRAD1: parathyroid adenomatosis 1)
, Cyclin-D1-binding protein 1 homolog
, cyclin Dx
, cyclin-D1-binding protein 1 homolog
, zebrafish homolog of Maid
, cyclin D1
, G1/S-specific cyclin-D1
, B-cell CLL/lymphoma 1
, B-cell lymphoma 1 protein
, BCL-1 oncogene
, PRAD1 oncogene
, G1/S-specific cyclin-D1 a
, cyclin D1 a (PRAD1: parathyroid adenomatosis 1)